#35: Oral antithrombotic agents: An update for the clinical practitioner with Dr Jonathan Halperin

After decades of reliance on warfarin, there are finally new options for oral anticoagulation, with exciting results from the RE-LY, ROCKET, and AVERROES trials paving the way for dabigatran, rivaroxaban, and apixaban.
Source: The Bob Harrington Show - Category: Cardiology Authors: Tags: The Bob Harrington Show Source Type: podcasts